ATLAS fair value
ATLAS has no fair value for this stock today.
Clover Health Investments stock price today, ATLAS forecast and fair value
Healthcare · Healthcare Plans · NASDAQ
Prices as of Oct 27, 2026 · USD
ATLAS has no fair value for this stock today.
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Clover Health Investments a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $4.16 and $5.07; in 9 out of 10, between $3.49 and $6.04. Estimated annual volatility is 50%.
ATLAS does not publish a fair value for CLOV right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks CLOV has traded between $1.58 and $5.59. Today it is 17.2% below that high and 193% above its low.
On the business: revenue grew 40.3% year over year; net margin is 4.4%.
Its beta is 2.48: it tends to move more than the market, both up and down.
Clover Health Investments, Corp. Class A Common Stock represents an equity interest in Clover Health Investments, Corp., a healthcare company focused on Medicare Advantage plans in the United States.
Want to see everything about Clover Health Investments?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Clover Health Investments, Corp. Class A Common Stock represents an equity interest in Clover Health Investments, Corp., a healthcare company focused on Medicare Advantage plans in the United States.
48%: close to a coin flip. In half of the simulated outcomes, CLOV ends the month between $4.16 and $5.07.
Clover Health Investments's market capitalization is $2.3B. We do not show a P/E because it has no positive earnings to base one on.
ATLAS estimates annual volatility at 50%. In a typical month, half of the outcomes end between $4.16 and $5.07.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy